Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.

RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...

PHILADELPHIA (WPVI) -- The human heart beats about a hundred thousand times a day. When the beat isn't regular, it's something called an arrhythmia. As we learn in today's Moves in Medicine, not all ...

MONTREAL and CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...

Photo Credit: AHA/Scott Morgan 2022. Used with permission. CHICAGO, IL—Full results of the RAPID trial testing etripamil nasal spray for patients with paroxysmal supraventricular tachycardia (PSVT) ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — A fast-acting nasal spray safely and effectively converted episodes of paroxysmal supraventricular ...

Fetal SVT was diagnosed in an unborn baby during a routine scan, presenting a life-threatening crisis. Doctors successfully ...

Pacing Clin Electrophysiol. 2005;28(12):1322-1346. The performance of SVT-VT discriminators is linked to boundaries between detection zones for ventricular arrhythmias. In Guidant ICDs, this link is ...

Heart arrhythmias are usually harmless, but some can be life threatening. Treatments help correct your heart rate to prevent serious health issues. When the electrical impulses that affect your ...

Doctors treating babies born with Turner syndrome need to look for heart rhythm abnormalities, in addition to the usual heart problems of high blood pressure or left-sided structural heart defects, ...

FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...